Osprey Medical (ASX:OSP) - President & CEO, Mike McCormick - The Market Herald

" Osprey Medical (ASX:OSP) signs distribution deal with RHCG for DyeVert tech

Osprey Medical (OSP) has struck a deal to have its tech distributed and sold in Australia and New Zealand for the first time.
Incannex Healthcare (ASX:IHL) - Chief Medical Officer, Dr Sud Agarwal (left) & CEO, Joel Latham (right) - The Market Herald

" Incannex Healthcare (ASX:IHL) receives ethics approval for OSA trial

Medicinal cannabis company Incannex Healthcare (IHL) has received ethics approval for a phase 2b clinical trial investigating its obstructive sleep apnoea (OSA) treatment.
MyFiziq (ASX:MYQ) - CEO & Co Founder, Vlado Bosanac - The Market Herald

" MyFiziq (ASX:MYQ) JV completes $2M funding round

MyFiziq (MYQ) joint venture company, Body Composition Technologies, has completed a $2 million funding round.
Aperion Investment Group- Founder, Christian Angermayer - The Market Herald

" Bionomics (ASX:BNO) receives FIRB approval for Aperion’s 52pc stake

Bionomics (BNO) has received Foreign Investment Review Board (FIRB) approval for Aperion Investment Group to nab a 52 per cent stake in the
PolyNovo (ASX:PNV) - CEO, Paul Brennan - The Market Herald

" PolyNovo (ASX:PNV) selects Finnish distributor

Healthcare giant PolyNovo (PNV) has selected Innova Medical Oy to distribute its clinical wound treatment in Finland.
Medlab (ASX:MDC)- CEO, Sean Hall - The Market Herald

" Medlab Clinical (ASX:MDC) recieves Australian patent for NanoCelle

Biotech company Medlab Clinical (MDC) has been granted an Australian patent for its NanoCelle delivery platform.
Proteomics receives CE Mark for kidney disease test

" BARD1 Life Sciences’ (ASX:BD1) ovarian cancer test kit passes muster

BARD1 Life Sciences (BD1) has received positive results from a trial of its improved ovarian cancer test kit.
Recce Pharmaceuticals (ASX:RCE) - CEO, James Graham - The Market Herald

" Recce Pharmaceuticals (ASX:RCE) completes $27.95M capital raise

Recce Pharmaceuticals (RCE) has completed its capital raise and successfully raised $27.95 million.
Atomo Diagnostics (ASX:AT1) - Co Founder & Managing Director, John Kelly - The Market Herald

" Atomo Diagnostics (ASX:AT1) to launch COVID-19 test in India

Atomo Diagnostics (AT1) has entered an agreement with PinkTech Design Private (DIVOC) to launch its COVID-19 antibody test in India.
Zelira Therapeutics (ASX:ZLD)- Chairman,Osagie Imasogie - The Market Herald

" Thorney Investment Group earns 5.2pc stake in Zelira Therapeutics (ASX:ZLD)

Medical cannabis company Zelira Therapeutics (ZLD) has a new substantial holder after Thorney Investment Group made a $2 million strategic investment.